Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10232-10241
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10232
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10232
Variable | Univariate analysis | Multivariate analysis | ||||
Hazard ratio | 95%CI | P value | Hazard ratio | 95%CI | P value | |
Number of high telomerase activity cells | ||||||
≤ 5 | 1.0 | 1.0 | ||||
> 5 | 3.566 | 0.988-12.88 | 0.052 | 1.971 | 0.471-8.861 | 0.350 |
fStage | ||||||
fStage I | 1.0 | 1.0 | ||||
fStage II | 3.635 | 0.169-37.96 | 0.337 | 3.576 | 0.166-37.35 | 0.343 |
fStage III | 17.78 | 4.065-121.8 | 0.0001b | 13.75 | 2.806-100.7 | 0.001b |
fStage IV | 239.6 | 7.943-7785 | 0.005b | 289.4 | 9.331-9733 | 0.004b |
- Citation: Ito H, Sato J, Tsujino Y, Yamaguchi N, Kimura S, Gohda K, Murakami K, Onimaru M, Ohmori T, Ishikawa F, Inoue H. Long-term prognostic impact of circulating tumour cells in gastric cancer patients. World J Gastroenterol 2016; 22(46): 10232-10241
- URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10232.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10232